Penumbra, Inc.
PEN
#1673
Rank
$12.725 B
Marketcap
United States
Country
$323.05
Share price
-0.99%
Change (1 day)
24.75%
Change (1 year)
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT…
Key Metrics
Trailing P/E
77.84
Forward P/E
51.79
EPS (TTM)
$4.08
Forward EPS
$6.13
Price / Book
8.17
EV / EBITDA
59.3x
Beta
0.70
Dividend Yield
—
Return on Equity
11.37%
Return on Assets
6.42%
Debt / Equity
13.90
Current Ratio
5.75
Gross Margin
67.84%
Operating Margin
10.52%
Net Profit Margin
10.67%
Free Cash Flow
$161.100M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
-2.83%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$1.404B
Latest Net Income$177.687M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Penumbra, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
PEN
No recent news available. Set FINNHUB_API_KEY to enable news.
